文献速递新发突发、热带与寄生虫病

母源性抗裂殖体逸出抗原-1抗体与婴儿重症疟疾的保护

Maternally-derived Antibodies to Schizont Egress Antigen-1 and Protection of Infants From Severe Malaria.
PubMed 文献 · Clin Infect Dis · 2019-01-01

在坦桑尼亚疟疾高度流行区纳入647名新生儿,检测脐血抗恶性疟原虫裂殖体逸出抗原-1(PfSEA-1)抗体并随访12个月。脐血抗PfSEA-1抗体高水平者重症疟疾病例数较低水平者减少51.4%(P=0.03)。小鼠实验中,母鼠接种PbSEA-1后其幼鼠在伯氏疟原虫ANKA攻击后虫血症更低、生存期更长。

要点

  • 脐血抗PfSEA-1抗体高水平与婴儿重症疟疾风险降低相关。
  • 高水平组12个月内重症疟疾病例数较低水平组减少51.4%(P=0.03)。
  • 母鼠接种PbSEA-1后幼鼠受伯氏疟原虫攻击时虫血症更低、生存更长。

核心结论

  • 母源性脐血抗PfSEA-1抗体预测婴儿重症疟疾风险降低。
  • 小鼠孕前接种PbSEA-1可保护其子代免受致死性伯氏疟原虫攻击。
  • 首次鉴定出保护婴儿免于重症疟疾的母体抗体寄生虫特异性靶点。
  • 作者认为孕妇接种PfSEA-1可能为其子代提供生存优势。

研究设计与样本

  • 坦桑尼亚疟疾高度流行区出生队列,纳入647名新生儿,采集脐血检测抗PfSEA-1抗体并随访12个月。
  • 小鼠实验:雌鼠接种PbSEA-1后交配,其幼鼠接受伯氏疟原虫ANKA攻击。

主要发现

  • 脐血抗PfSEA-1抗体高水平儿童12个月随访期间重症疟疾病例数较高水平低者减少51.4%(P=0.03)。
  • 3项试验中,PbSEA-1接种母鼠所生幼鼠在伯氏疟原虫攻击后虫血症显著更低、生存期更长(与对照母鼠所生幼鼠比较)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In holoendemic areas, children suffer the most from Plasmodium falciparum malaria, yet newborns and young infants express a relative resistance to both infection and severe malarial disease (SM). This relative resistance has been ascribed to maternally-derived anti-parasite immunoglobulin G; however, the targets of these protective antibodies remain elusive. METHODS: We enrolled 647 newborns at birth from a malaria-holoendemic region of Tanzania. We collected cord blood, measured antibodies to Plasmodium falciparum Schizont Egress Antigen-1 (PfSEA-1), and related these antibodies to the risk of severe malaria in the first year of life. In addition, we vaccinated female mice with PbSEA-1, mated them, and challenged their pups with P. berghei ANKA parasites to assess the impact of maternal PbSEA-1 vaccination on newborns' resistance to malaria. RESULTS: Children with high cord-blood anti-PfSEA-1 antibody levels had 51.4% fewer cases of SM compared to individuals with lower anti-PfSEA-1 levels over 12 months of follow-up (P = .03). In 3 trials, pups born to PbSEA-1-vaccinated dams had significantly lower parasitemia and longer survival following a P. berghei challenge compared to pups born to control dams. CONCLUSIONS: We demonstrate that maternally-derived, cord-blood anti-PfSEA-1 antibodies predict decreased risk of SM in infants and vaccination of mice with PbSEA-1 prior to pregnancy protects their offspring from lethal P. berghei challenge. These results identify, for the first time, a parasite-specific target of maternal antibodies that protect infants from SM and suggest that vaccination of pregnant women with PfSEA-1 may afford a survival advantage to their offspring.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Kurtis JD, Raj DK, Michelow IC, et al. Maternally-derived Antibodies to Schizont Egress Antigen-1 and Protection of Infants From Severe Malaria. Clin Infect Dis. 2019. PMID: 30165569. doi:10.1093/cid/ciy728

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。